NOBIVAC® CANINE 1-DAPPv + Cv

A modified live vaccine for the immunisation of healthy dogs against canine distemper virus, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus, leptospirosis and corona virus.

FOR ANIMAL USE ONLY

NOBIVAC® CANINE 1 -DAPPVL2 + CV

Reg. No. G3893 (Act 36/1947)

Namibia Reg. No. V07/24.1/902 [NS2]

This vaccine may only be used by or under the supervision of persons registered in terms of or authorised in terms of section 23 (1) (c) of the Veterinary and Para-veterinary Professions Act, 1982 (Act No. 19 of 1982).

INDICATIONS

A modified live vaccine for the immunisation of healthy dogs against canine distemper virus, adenovirus type 2, infectious canine hepatitis, parainfluenza, parvovirus, leptospirosis and corona virus.

COMPOSITION

Modified live vaccine containing canine distemper virus, adenovirus type 2, parainfluenza virus, parvovirus type 2b strain, killed feline enteric corona virus and inactivated Leptospira (L. canicola and L. icterohaemorrhagiae) bacterin.

Maximum moisture content at release: ≤ 5,5 %.

Contains gentamicin and thimerosal as preservative.

STORAGE INSTRUCTIONS

  • Store between 2 °C – 8 °C in a refrigerator.
  • Do not freeze.
  • Protect from light.
  • Use entire contents immediately after reconstitution.

WARNINGS

  • DO NOT VACCINATE PREGNANT BITCHES.
  • Vaccinate only healthy, non-parasitised dogs.
  • Do not mix Nobivac® Canine 1 -DAPPVL2 + CV with any other vaccine or medication.
  • Do not over- or underdose the vaccine.
  • Do not inject intravenously.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Observe aseptic precautions. Ensure that all vaccination equipment (containers, syringes and needles) is clean and sterile prior to and during use. Use sterile equipment when administering the vaccine.
  • Do not use disinfectants or antiseptics to sterilise any equipment.
  • Anaphylactic or hypersensitivity reactions may occur.
  • Adhere to the vaccination programme to obtain optimum results.
  • Do not eat, drink or smoke whilst handling the product.
  • Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).
  • Do not contaminate rivers, dams or any water sources with containers or waste.

Antidote: Adrenaline, corticosteroids and antihistamines may all be indicated depending on the nature and severity of the reaction.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

  • Shake the Cv diluent vial and transfer its contents to the Nobivac® Canine 1-DAPPvL2 vial aseptically.
  • Gently mix until well dissolved.
  • Inject subcutaneously or intramuscularly at 6 weeks of age or older.
  • Repeat dosage at 2 to 4 week intervals until the dog is 12 weeks old.
  • A minimum of two 1 mℓ doses are required for primary immunisation.
  • Although duration of immunity is at least 4 years for distemper, adenovirus (CAV1 and CAV2) and parvovirus.
  •  Annual revaccination with one dose is recommended for the individual risk profile or immune status.

PRESENTATION

Type I glass vials, containing off-white freeze-dried vaccine, closed with a rubber stopper and sealed with an aluminum cap. Nobivac® Canine 1-DAPPvL2 vials are accompanied by Cv diluent vials in a polyvinyl chloride (PVC) tray, which contains 25 vials of 1 dose (1 mℓ) or 5 vials of 10 doses (10 mℓ). Carton must be sold as a unit. Do not break seal or open before sale.

REGISTRATION HOLDER                                                      

Intervet South Africa (Pty) Ltd.                                           

20 Spartan Road, Spartan                                                      

RSA, 1619                                                                                          

Tel. +27 (0) 11 923 9300                                                            

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT 14 December 2010